Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
RATIONALE: Romiplostim may cause the body to make platelets. PURPOSE: This randomized phase II trial is studying how well romiplostim works in treating hepatitis C-infected patients with thrombocytopenia.
Epistemonikos ID: 6e732d8f5300dab540dad7f223fffefebc323c59
First added on: May 05, 2024